Ngā hua rapu - Hilde Decraemer

  • E whakaatu ana i te 1 - 2 hua o te 2
Whakamahine hua
  1. 1
    Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy

    Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy mā Man‐Fung Yuen, Erwin Sablon, Chee Kin Hui, He-Jun Yuan, Hilde Decraemer, Ching‐Lung Lai

    I whakaputaina 2001
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Monitoring Drug Resistance in Chronic Hepatitis B Virus (HBV)-Infected Patients during Lamivudine Therapy: Evaluation of Performance of INNO-LiPA HBV DR Assay

    Monitoring Drug Resistance in Chronic Hepatitis B Virus (HBV)-Infected Patients during Lamivudine Therapy: Evaluation of Performance of INNO-LiPA HBV DR Assay mā Anna S. Lok, Fabien Zoulim, Stephen Locarnini, Alessandra Mangia, Grazia Anna Niro, Hilde Decraemer, Geert Maertens, Frank Hulstaert, K De Vreese, Erwin Sablon

    I whakaputaina 2002
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: